Artificial Intelligence and Hepatocellular Carcinoma

To identify new relevant biomarkers for HCC patients and their risk of recurrence. Radiomics data and computer-vision data will be explored for their ability to predict the presence of particular pathological signs of aggressiveness (microvascular invasion and satellitosis), and the prognosis after surgery.

Inclusion Criteria:Age >= 18 years old.Hepatocarcinoma diagnosis confirmed at histological specimenBeing at the first HCC diagnosis or with a recurrence/persistence disease evaluated and treated for the first time with surgery at the participating center.Available contrast-enhanced CT Scan obtained no more than 1 month prior to surgery.Exclusion Criteria:Surgery as a downstaging therapy for transplantPatients treated with surgery in case of not-curative intent (palliation, best supportive care, etc).Histopathological specimen of combined liver primary neoplasms (e.g. 'epatocolangiocarcinoma').